Sec Form 4 Filing - Soni Manmeet Singh @ PHARMACYCLICS INC - 2015-03-11

FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: November 30, 2011 Estimated average burden hours per response... 0.5

1. Name and Address of Reporting Person Soni Manmeet Singh 2. Issuer Name and Ticker or Trading Symbol PHARMACYCLICS INC [ PCYC] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner X __ Officer (give title below) _____ Other (specify below) Chief Financial Officer (Last) (First) (Middle) C/O PHARMACYCLICS, INC., 995 EAST ARQUES AVE 3. Date of Earliest Transaction (MM/DD/YY) 03/11/2015 (Street) SUNNYVALE, CA94085 4. If Amendment, Date Original Filed (MM/DD/YY) 6. Individual or Joint/Group Filing (Check Applicable Line) __ X __ Form filed by One Reporting Person _____ Form filed by More than One Reporting Person (City) (State) (Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1.Title of Security (Instr. 3) 2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/11/2015 M 7,848 A $ 61.6 65,875 D Common Stock 03/11/2015 M 5,000 A $ 106.75 70,875 D Common Stock 03/11/2015 M 11,250 A $ 70.37 82,125 D Common Stock 03/11/2015 S 24,098 D $ 254.15 58,027 D Common Stock 03/13/2015 S 902 D $ 254.88 57,125 D Common Stock 03/13/2015 S 2,514 D $ 254.914 54,611 D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) 6. Date Exercisable and Expiration Date (MM/DD/YY) 7. Title and Amount of Underlying Securities (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Stock Option (Right to Buy) $ 61.6 03/11/2015 M 7,848 10/26/2012( 1 ) 10/26/2022 Common Stock 7,848 $ 0 11,152 D Stock Option (Right to Buy) $ 106.75 03/11/2015 M 5,000 08/16/2013( 2 ) 08/16/2023 Common Stock 5,000 $ 0 15,000 D Stock Option (Right to Buy) $ 70.37 03/11/2015 M 11,250 02/12/2013( 3 ) 02/12/2023 Common Stock 11,250 $ 0 18,750 D

Reporting Owners Reporting Owner Name / Address Relationships Director 10% Owner Officer Other Soni Manmeet Singh C/O PHARMACYCLICS, INC. 995 EAST ARQUES AVE SUNNYVALE, CA94085 Chief Financial Officer Signatures /s/ Manmeet S. Soni 03/13/2015 Signature of Reporting Person Date

Explanation of Responses:

( 1 )The shares subject to the option will vest as follows: 25% of the shares subject to the option will vest on September 6, 2013 and 1/36th of the remaining shares will vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested on September 6, 2016, subject to the Reporting Person's continued employment or service relationship with the Issuer on each of the vesting dates. ( 2 )The option vests 12/48ths shall vest on each of August 16, 2014, August 16, 2015 and August 16, 2016 and August 16,2017. The vesting of the options is subject to satisfaction of certain performance criteria. ( 3 )The option vests 3/48 on April 11, 2013; the remainder vests proportionately on each of April 11, 2014, April 11, 2015 and April 11, 2016, subject to satisfaction of certain performance criteria with respect to each such period.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4(b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.